Differential disease phenotypes and progression in relapsing–remitting multiple sclerosis: comparative analyses of single Canadian and Saudi Arabian clinics
Mohammad Alluqmani(University of Alberta), Christopher Power(University of Alberta), Gregg Blevins, Weston Roda(University of Alberta), Fabrizio Giuliani(University of Alberta), M. Qqrmli(Taibah University)
Cited by 6
Related Papers
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
|Nature Medicine|2007|1.8k
International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
|Pharmacological Reviews|2013|849
The Role of Inflammation in Depression and Fatigue
|Frontiers in Immunology|2019|651
The promise of minocycline in neurology
|The Lancet Neurology|2004|521